MBC BioLab’s first company, Alector, is getting ready to go public
Alector moved into MBC BioLabs on the day we opened our doors, and now just over five years later they have two programs in the clinic, a partnership with AbbVie, and are now are preparing to g [...]
Cypre and Molecular Devices sign co-marketing agreement to collaborate on delivering solutions for screening biologically relevant assays
Kolin Hribar, PhD, CEO and Founder of Cypre Inc. with their Symphony®/VersaGel® Cypre and Molecular Devices signed a co-marketing agreement to jointly market Cypre’s Symphony®/VersaGel® 3D cel [...]
Announcing Recipients of the Golden Ticket Program
Nitrome Biosciences and SyntheX are the recipients of the MBC 2018 Golden Ticket program sponsored by Celgene Corporation.
Peninsula Alzheimer’s fighter hunts $150 million IPO
Alector's Arnon Rosenthal (left) and Sabah Oney. TODD JOHNSON | SAN FRANCISCO BUSINESS TIMES By Ron Leuty – Reporter, San Francisco Business Times Jan 7, 2019, 5:18pm EST Read original online a [...]
Apply for the 2019 AbbVie Golden Ticket by Friday 2/1/2019!
AbbVie and MBC BioLabs invite you to apply for the 2019 AbbVie Golden Ticket!
Japanese Life Science Innovation
January 10, 2019 2:30 - 4:30pm Beyond Next Ventures and MBC BioLabs invite you to explore the latest in Japanese life science innovation on January 10th, when seven startups specially selected for t [...]
Prellis Biologics and CELLINK Sign Partnership
Prellis Biologics and CELLINK Sign Partnership Prellis Biologics and CELLINK sign partnership to commercialize high-resolution holographic bioprinting technology for micro-printing.The partners [...]